http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101465415-B1

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-501
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-501
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
filingDate 2007-07-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2014-11-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2014-11-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-101465415-B1
titleOfInvention Cognitive function improvement and neuroprotective agents
abstract The present invention relates to the use of 4-chloro-5- {2- [4- (6-fluoro-1, 2- Yl] ethyl-amino} -2-methyl-3- (2H) pyridazinone or a pharmaceutically acceptable salt thereof. 1-yl] ethyl-amino} -piperazin-1-yl) piperazin-1-yl] -2-methyl-3- (2H) pyridazinone or a therapeutically acceptable salt thereof is useful for the treatment or prevention of neuropathies, psychosis, multiple sclerosis, Creutzfeldt-Jacob disease, Huntington's syndrome, amyotrophic lateral sclerosis, Parkinson's disease, memory impairment, memory loss, memory loss or stroke, or may be used for the improvement of memory function or learning ability:
priorityDate 2006-07-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03010166-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68153
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5073
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421273617
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426387251
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507784
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID10116
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9283
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396945
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID673473
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4737
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3000322
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID10116
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394683
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12200169
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407318370
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393767
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507462
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6954
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451783488
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419484542
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535600

Total number of triples: 42.